JEF Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Jefferies Financial (JEF) is currently trading at $57.45 as of 2025-03-10. The stock has shown signs of being oversold, with an RSI of 12.93, indicating potential for a short-term rebound. The MACD is currently negative, suggesting downward momentum, but the low RSI may signal a reversal.
Fibonacci Levels:
The Fibonacci levels for JEF are as follows:
- Pivot Point: $61.41
- R1 (Resistance): $66.02
- S1 (Support): $56.80
The stock is currently trading below the pivot point, indicating bearish sentiment. However, the proximity to the support level suggests that a bounce could occur if the stock finds buying interest at these levels.
News Sentiment and Analyst Opinion:
Goldman Sachs recently lowered its price target for JEF from $79 to $75, maintaining a Buy rating. This adjustment reflects weaker-than-expected investment banking activity and market uncertainty. Despite this, the stock's current valuation and oversold condition may present a buying opportunity for those looking to capitalize on a potential rebound.
Prediction and Recommendation:
Based on the technical indicators and news sentiment, the stock is likely to experience a short-term rebound. The target price for the next trading week is $66.00, with the potential to test the first resistance level at $66.02.
Recommendation: Buy JEF with a target price of $66.00, as the stock is oversold and due for a technical bounce.
JEF Similar Chart Price Prediction
The price of JEF is predicted to go up -3%, based on the high correlation periods with EVR. The similarity of these two price pattern on the periods is 98.97%.
JEF
EVR
Down: -3%Similarity: 98.97%
JEF Revenue Forecast
JEF EPS Forecast
JEF FAQs
What is JEF revenue forecast for next quarter？
JEF Analyst's Forecast
Ryan Kenny
Morgan Stanley
Buy
2025-03-13
Price Target
$92 → $81
Upside
+49.28%
Morgan Stanley lowered the firm's price target on Jefferies Financial to $81 from $92 and keeps an Overweight rating on the shares. The robust capital markets rebound the firm expected in 2025 is not playing out as anticipated and the firm is lowering its estimates for investment banking revenues on the back of recent market conditions as volatility likely pushes out deal launches. However, large-cap bank and mid-cap advisor stocks "appear oversold against our new base case," the analyst tells investors.
Chris Kotowski
Oppenheimer
Buy
2025-01-03
Price Target
$82 → $81
Downside
0%
Ryan Kenny
Morgan Stanley
Hold → Buy
2024-12-09
Price Target
$67 → $97
Upside
+23.68%
